¡¾²Î¿¼ÎÄÏס¿
  1 Yan Y, Wang L. Recent advance of the study on pathogenesis of ageª²related macular degeneration. Int J Ophthalmol(Guoji Yanke Zazhi)2008;8(9):1888ª²1890

2 Frank RN, Amin RH, Eliott D, et al. Basic fibroblast growth factor and vascular endothelial growth factor are present in epiretinal and choroidal neovascular membranes. Am J Ophthalmol 1996;122(3):393ª² 403

3 Lopez PF, Sippy BD, Lambert HM, et al. Transdifferentiated retinal pigment epithelial cells are immunoreactive for vascular endothelial growth factor in surgically excised ageª²related macular degenerationª²related choroidal neovascular membranes. Invest Ophthalmol Vis Sci 1996;37(5):855ª²868

4 Shen WY, Yu MJ, Barry CJ, et al. Expression of cell adhesion molecules and vascular endothelial growth factor in experimental choroidal neovascularisation in the rat. Br J Ophthalmol 1998;82(9):1063ª²1071

5 Honda M, Sakamoto T, Ishibashi T, et al. Experimental subretinal neovascularization is inhibited by adenovirusª²mediated soluble VEGF/fltª²1 receptor gene transfection: a role of VEGF and possible treatment for SRN in ageª²related macular degeneration. Gene Ther 2000;7(11):978ª²985

6 Krzystolik MG, Afshari MA, Adamis AP, et al. Prevention of experimental choroidal neovascularization with intravitreal antiª²vascular endothelial growth factor antibody fragment. Arch Ophthalmol 2002;120(3):338ª²346

7 Schwesinger C, Yee C, Rohan RM, et al. Intrachoroidal neovascularization in transgenic mice overexpressing vascular endothelial growth factor in the retinal pigment epithelium. Am J Pathol 2001;158(3):1161ª²1172

8 Ogata N, Matsushima M, Takada Y, et al. Expression of basic fibroblast growth factor mRNA in developing choroidal neovascularization.

Curr Eye Res 1996;15(10):1008ª²1018

9 Tobe T, Ortega S, Luna JD, et al. Targeted disruption of the FGF2 gene does not prevent choroidal neovascularization in a murine model.

Am J Pathol 1998;153(5):1641ª² 1646

10 Yamada H, Yamada E, Kwak N, et al. Cell injury unmasks a latent proangiogenic phenotype in mice with increased expression of FGF2 in the retina. J Cell Physiol 2000;185(1):135ª²142

11 Takahashi T, Nakamura T, Hayashi A, et al. Inhibition of experimental choroidal neovascularization by overexpression of tissue inhibitor of metalloproteinasesª²3 in retinal pigment epithelium cells. Am J Ophthalmol 2000;130(6):774ª²781

12 Dawson DW, Volpert OV, Gillis P, et al. Pigment epitheliumª²derived factor: a potent inhibitor of angiogenesis. Science 1999;285(5425):245ª²248

13 Gao G, Li Y, Zhang D, et al. Unbalanced expression of VEGF and PEDF in ischemiaª²induced retinal neovascularization. FEBS Lett 2001;489(2ª²3):270ª²276

14 Holekamp NM, Bouck N, Volpert O. Pigment epitheliumderived factor is deficient in the vitreous of patients with choroidal neovascularization due to ageª²related macular degeneration. Am J Ophthalmol2002;134(2): 220ª²227

15 Green WR, Enger C. Ageª²related macular degeneration histopathologic studies. Ophthalmology1993;100(10):1519ª²1535

16 Young RW. Pathophysiology of ageª²related macular degeneration. Surv

Ophthalmol 1987;31(5):291ª²306

17 Del Priore LV, Hornbeck R, Kaplan HJ,et al. Debridement of the pig retinal pigment epithelium in vivo. Arch Ophthalmol 1995;113(7):939ª²944

18 Blaauwgeers HG, Holtkamp GM, Rutten H, et al. Polarized vascular endothelial growth factor secretion by human retinal pigment epithelium and localization of vascular endothelial growth factor receptors on the inner choriocapillaris. Evidence for a trophic paracrine relation. Am J

Pathol 1999;155(2):421ª²428

19 Chow J, Ogunshola O, Fan SY, et al. Astrocyteª²derived VEGF mediates survival and tube stabilization of hypoxic brain microvascular endothelial cells in vitro. Brain Res Dev Brain Res 2001;130(1):123ª²132

20 Smith LE, Wesolowski E, McLellan A, et al. Oxygenª²induced retinopathy in the mouse. Invest Ophthalmol Vis Sci1994;35(1):101ª²111

21 Aiello LP, Pierce EA, Foley ED, et al. Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGFª²receptor chimeric proteins. Proc Natl Acad

Sci USA 1995;7;92(23):10457ª²10461

22 Chanª²Ling T, Gock B , Stone J. Supplemental oxygen therapy. Basis for noninvasive treatement of retinopathy of prematurity. Invest Opthalmol

Vis Sci1995;36(7):1215ª²1230

23 Shima DT, Gougos A, Miller JW, et al. Cloning and mRNA expression of vascular endothelial growth factor in ischemic retinas of Macaca fasicularis. Invest Ophthalmol Vis Sci 1996;37(7):1334ª²1340

24 Adamis AP, Shima DT, Tolentino MJ, et al. Inhibition of VEGF prevents ocular neovascularization in a primate. Arch Ophthalmol1996;114(1):66ª²71

25 Malecaze F, Clamens S, Simorreª²Pinatel V,et al. Detection of vascular endothelial growth factor messenger RNA and vascular endothelial growth factorlike activity in proliferative diabetic retinopathy. Lab Sci 1994;112(11):1476ª²1482

ÉÏÒ»Ò³  [1] [2]